Novel Protocol for Rapid Desensitization of Melphalan in a 5-Year-Old Boy Undergoing Conditioning for Hematopoietic Stem Cell Transplantation: A Case Report

Novel Protocol for Rapid Desensitization of Melphalan in a 5-Year-Old Boy Undergoing Conditioning for Hematopoietic Stem Cell Transplantation: A Case Report

Hematopoietic stem cell transplantation is a potentially life-saving therapy under certain conditions. Hypersensitivity reaction to chemotherapeutic drugs may interfere with this treatment. Griscelli syndrome type 2 is a rare autosomal recessive disease characterized by hypopigmentation of skin and...

Full description

Bibliographic Details
Main Authors:	Bibi Shahin Shamsian, Delara Babaei, Mohammad Naderisorki
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2020-10-01
Series:	Middle East Journal of Cancer
Subjects:	rapid desensitization melphalan hematopoietic stem cell transplantation child
Online Access:	https://mejc.sums.ac.ir/article_46788_15f5af3daf2e2c5a6032523f3573ee89.pdf

Similar Items

Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myeloma
by: Deepesh P. Lad, et al.
Published: (2021-06-01)

Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma
by: Morabito F, et al.
Published: (2021-07-01)

Successful rapid oral desensitization for dual hypersensitivity to isoniazid and rifampin while treating central nervous system tuberculosis
by: Moni Roy, et al.
Published: (2018-11-01)

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
by: Se Ryeon Lee, et al.
Published: (2019-11-01)

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients
by: Kang Xue, et al.
Published: (2019-02-01)

Melphalan flufenamide inhibits osteoclastogenesis by suppressing proliferation of monocytes
by: Konstantin Byrgazov, et al.
Published: (2021-12-01)

Atypical lichen myxedematosus: A case with remarkable response to low dose melphalan
by: Mini Gomathy, et al.
Published: (2017-01-01)

Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical hematopoietic stem cell transplantation
by: Rasika Dhawan Setia, et al.
Published: (2019-01-01)

Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
by: SV Gritsaev, et al.
Published: (2019-05-01)

Melphalan as a Promising Treatment for BRCA-Related Ovarian Carcinoma
by: Vincenza Conteduca, et al.
Published: (2021-07-01)

Preclinical Studies of the Melphalan Prodrug J1 for Cancer Therapy
by: Wickström, Malin
Published: (2007)

Identifying responders to melphalan and dexamethasone for newly diagnosed multiple myeloma patients
by: Esmaeili, Abbas
Published: (2008)

Safety and Efficacy of Intravitreal Chemotherapy (Melphalan) to Treat Vitreous Seeds in Retinoblastoma
by: Yacoub A. Yousef, et al.
Published: (2021-07-01)

Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability
by: Stefano Guadagni, et al.
Published: (2017-08-01)

Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
by: Taleb Azarm, et al.
Published: (2012-01-01)

Successful treatment of ciliary body medulloepithelioma with intraocular melphalan chemotherapy: a case report
by: Christina Stathopoulos, et al.
Published: (2020-06-01)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
by: Junko Johansson, et al.
Published: (2018-12-01)

Comparing cytotoxicity of parthenolide, melphalan, and procarbazine in colon adenocarcinoma and hepatocellular carcinoma cells
by: Fatemeh B. Rassouli
Published: (2018-08-01)

Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation
by: Gabriele Buda, et al.
Published: (2021-08-01)

The Use of Systematic Desensitization in the Prevention of Pervasive Anxiety
by: Jaremko, Matthew E.
Published: (1972)

Use of Systematic Desensitization to Prevent the Learning of Specific Autonomic Responses
by: Jaremko, Matthew Emmett
Published: (1976)

Phosphatidylinositol Stabilizes Fluid-Phase Liposomes Loaded with a Melphalan Lipophilic Prodrug
by: Daria Tretiakova, et al.
Published: (2021-04-01)

Imaginal Response Events in Systematic Desensitization
by: Glenn, Sigrid S., 1939-
Published: (1977)

Complete Remission of a Refractory Acute Myeloid Leukemia with Myelodysplastic- and Monosomy 7-Related Changes after a Combined Conditioning Regimen of Plerixafor, Cytarabine and Melphalan in a 4-Year-Old Boy: A Case Report and Review of Literature
by: Antonio G. Grasso, et al.
Published: (2018-08-01)

MELPHALAN-INDUCED CYTOTOXICITY IN THE BONE MARROW OF RATS BY FLOW CYTOMETRY MEASUREMENTS
by: B I. Gerashchenko, et al.
Published: (2019-03-01)

Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells
by: Claire Gourzones, et al.
Published: (2019-03-01)

Combined intra-arterial chemotherapy and intravitreal melphalan for the treatment of advanced unilateral retinoblastoma
by: Ting-Yi Liang, et al.
Published: (2020-02-01)

Pharmacokinetics and pharmacodynamics of melphalan in multiple myeloma patients to predict clinical adverse outcomes
by: Cho, Yu Kyoung
Published: (2016)

Effect of Primary and Secondary Beads of Carbon Enterosorbent on Haematological Parameters and Oxidative Stress Development Caused by Melphalan in Rats
by: Oksana Shevchuk, et al.
Published: (2019-09-01)

Investigation of characterization and cytotoxic effect of PEGylated nanoliposomal containing Melphalan on ovarian cancer: an in vitro study
by: Seyedeh Masoomeh Sadat Mirnezami, et al.
Published: (2021-01-01)

The efficacy of self-administered systematic desensitization
by: Horowitz, Neil D.
Published: (1977)

Pars plana vitrectomy under melphalan irrigation for recurrent retinal detachment in eyes treated for retinoblastoma: a case report
by: Christina Stathopoulos, et al.
Published: (2020-01-01)

[Morphological aspects of protective influence of carbonic enterosorbent and granulocyte colony stimulating factor on small intestine in case of Melphalan administration]
by: Shevchuk O.O.
Published: (2015-09-01)

EFFICACY OF GRANULOCYTE COLONY-STIMULATING FACTOR AND ENTEROSORPTION IN MELPHALAN-INDUCED BONE MARROW SUPPRESSION IN GUERIN CARCINOMA GRAFTED RATS
by: O. O. Shevchuk, et al.
Published: (2019-07-01)

Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
by: Junko Johansson, et al.
Published: (2020-01-01)

Rapid Desensitization with Autologous Sweat in Cholinergic Urticaria
by: Takeshi Kozaru, et al.
Published: (2011-01-01)

Insight versus Desensitization: a Comparative Study
by: Juda, Robert A.
Published: (1971)

Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
by: Thomas Mika, et al.
Published: (2020-12-01)

A case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrest
by: Liang-Liang Ma, et al.
Published: (2020-03-01)

Interdisciplinary Medical And Dental Desensitization For People With Autism
by: Victoria Babikian, et al.
Published: (2020-08-01)